Sanofi’s dupixent approved in the US as the first-ever biologic medicine for patients with COPD
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
She brings an overall Techno Commercial experience of 22+ Years in various Organizations
Konieczny has served as Interim CEO since April 2024
Vonoprazan is used in the treatment of disorders related to Gastroesophageal Reflux Disease (GERD)
The new facility further improves the operational efficiency and readies the site for the completion of the new large-scale production plant
e brings over 27+ years of rich pharmaceutical experience
New Chair brings extensive experience in global pharmaceutical and biotechnology leadership, healthcare innovation, and strategic drug development
Patni brings over 25 years of distinguished experience in the pharmaceutical industry
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
Subscribe To Our Newsletter & Stay Updated